1-20 of 75
maturity onset diabetes mellitus in young
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 Diabetes

Raymond J. Kreienkamp, Beverley M. Shields, Toni I. Pollin, Amy S. Shah, Angela D. Liese, Anna Bellatorre, Catherine Pihoker, Mustafa Tosur, Jose C. Florez, Shylaja Srinivasan, Andrew T. Hattersley, Miriam S. Udler, Maria J. Redondo
Journal: Diabetes Care
Diabetes Care 2025;48(1):e3–e5
https://doi.org/10.2337/dc24-1565
Published: 18 November 2024
View article titled, MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 Diabetes
Open the PDF for MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 Diabetes in another window
Journal Articles

Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY

David T. Broome, Alina Mehdi, Colby Chase, Maria Foss de Freitas, Brigid E. Gregg, Elif A. Oral, William H. Herman
Journal: Diabetes Care
Diabetes Care 2024;47(9):e65–e66
https://doi.org/10.2337/dc24-0730
Published: 24 July 2024
View article titled, Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY
Open the PDF for Use of a Dual GIP/GLP-1 Receptor Agonist in HNF1A-MODY and HNF4A-MODY in another window
Journal Articles

Hypoglycemic Response to Dorzagliatin in a Patient With GCK-MODY

Yilin Zhao, Yumin Ma, Tianhao Ba, Xueyao Han, Qian Ren, Linong Ji
Journal: Diabetes Care
Diabetes Care 2024;47(7):1140–1142
https://doi.org/10.2337/dc23-2417
Published: 01 May 2024
View article titled, Hypoglycemic Response to Dorzagliatin in a Patient With GCK-MODY
Open the PDF for Hypoglycemic Response to Dorzagliatin in a Patient With GCK-MODY in another window
Journal Articles

Atypical Diabetes: What Have We Learned and What Does the Future Hold?

Stephen I. Stone, Ashok Balasubramanyam, Jennifer E. Posey
Journal: Diabetes Care
Diabetes Care 2024;47(5):770–781
https://doi.org/10.2337/dci23-0038
Published: 08 February 2024
View article titled, Atypical Diabetes: What Have We Learned and What Does the Future Hold?
Open the PDF for Atypical Diabetes: What Have We Learned and What Does the Future Hold? in another window
Journal Articles

Objective and Subjective Sleep Patterns in Adults With Maturity-Onset Diabetes of the Young (MODY)

Marilyn Arosemena, Maria V. Salguero, Rochelle N. Naylor, Kristen Wroblewski, Esra Tasali, Louis H. Philipson
Journal: Diabetes Care
Diabetes Care 2023;46(3):608–612
https://doi.org/10.2337/dc22-1343
Published: 13 January 2023
View article titled, Objective and Subjective Sleep Patterns in Adults With Maturity-Onset Diabetes of the Young (MODY)
Open the PDF for Objective and Subjective Sleep Patterns in Adults With Maturity-Onset Diabetes of the Young (MODY) in another window
Journal Articles

SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY

Shigeru Suzuki, Takahide Kokumai, Akiko Furuya, Satoru Takahashi
Journal: Diabetes Care
Diabetes Care 2023;46(3):e74–e75
https://doi.org/10.2337/dc22-1573
Published: 04 January 2023
View article titled, SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY
Open the PDF for SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY in another window
Journal Articles

Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine Program

Haichen Zhang, Jeffrey W. Kleinberger, Kristin A. Maloney, Yue Guan, Trevor J. Mathias, Katharine Bisordi, Elizabeth A. Streeten, Kristina Blessing, Mallory N. Snyder, Lee A. Bromberger, Jessica Goehringer, Amy Kimball, Coleen M. Damcott, Casey O. Taylor, Michaela Nicholson, Devon Nwaba, Kathleen Palmer, Danielle Sewell, Nicholas Ambulos, Linda J.B. Jeng, Alan R. Shuldiner, Philip Levin, David J. Carey, Toni I. Pollin
Journal: Diabetes Care
Diabetes Care 2022;45(8):1799–1806
https://doi.org/10.2337/dc21-1975
Published: 26 July 2022
View article titled, Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine Program
Open the PDF for Model for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine Program in another window
Journal Articles

Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.K.

Lewis Pang, Kevin C. Colclough, Maggie H. Shepherd, Joanne McLean, Ewan R. Pearson, Sian Ellard, Andrew T. Hattersley, Beverley M. Shields
Journal: Diabetes Care
Diabetes Care 2022;45(3):642–649
https://doi.org/10.2337/dc21-2056
Published: 21 January 2022
View article titled, Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.K.
Open the PDF for Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.K. in another window
Journal Articles

Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum

Matthew C. Riddle, Louis H. Philipson, Stephen S. Rich, Annelie Carlsson, Paul W. Franks, Siri Atma W. Greeley, John J. Nolan, Ewan R. Pearson, Philip S. Zeitler, Andrew T. Hattersley
Journal: Diabetes Care
Diabetes Care 2020;43(12):3117–3128
https://doi.org/10.2337/dci20-0065
Published: 12 November 2020
View article titled, Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a <em>Diabetes Care</em> Editors’ Expert Forum
Open the PDF for Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a <em>Diabetes Care</em> Editors’ Expert Forum in another window
Journal Articles

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

Alexander S. Christensen, Sofie Hædersdal, Julie Støy, Heidi Storgaard, Ulla Kampmann, Julie L. Forman, Marta Seghieri, Jens J. Holst, Torben Hansen, Filip K. Knop, Tina Vilsbøll
Journal: Diabetes Care
Diabetes Care 2020;43(9):2025–2033
https://doi.org/10.2337/dc20-0408
Published: 13 July 2020
View article titled, Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)
Open the PDF for Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA) in another window
Journal Articles

Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY

David T. Broome, Zehra Tekin, Kevin M. Pantalone, Adi E. Mehta
Journal: Diabetes Care
Diabetes Care 2020;43(6):e65
https://doi.org/10.2337/dc20-0012
Published: 07 April 2020
View article titled, Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY
Open the PDF for Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY in another window
Journal Articles

Homozygous Hypomorphic HNF1A Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes

Shivani Misra, Neelam Hassanali, Amanda J. Bennett, Agata Juszczak, Richard Caswell, Kevin Colclough, Jonathan Valabhji, Sian Ellard, Nicholas S. Oliver, Anna L. Gloyn
Journal: Diabetes Care
Diabetes Care 2020;43(4):909–912
https://doi.org/10.2337/dc19-1843
Published: 30 January 2020
View article titled, Homozygous Hypomorphic <em>HNF1A</em> Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes
Open the PDF for Homozygous Hypomorphic <em>HNF1A</em> Alleles Are a Novel Cause of Young-Onset Diabetes and Result in Sulfonylurea-Sensitive Diabetes in another window
Includes: Supplementary data
Journal Articles

Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study

Annelie Carlsson, Maggie Shepherd, Sian Ellard, Michael Weedon, Åke Lernmark, Gun Forsander, Kevin Colclough, Qefsere Brahimi, Camilla Valtonen-Andre, Sten A. Ivarsson, Helena Elding Larsson, Ulf Samuelsson, Eva Örtqvist, Leif Groop, Johnny Ludvigsson, Claude Marcus, Andrew T. Hattersley
Journal: Diabetes Care
Diabetes Care 2020;43(1):82–89
https://doi.org/10.2337/dc19-0747
Published: 12 December 2019
View article titled, Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study
Open the PDF for Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study in another window
Includes: Supplementary data
Journal Articles

In This Issue of Diabetes Care

Journal: Diabetes Care
Diabetes Care 2020;43(1):1–2
https://doi.org/10.2337/dc20-ti01
Published: 12 December 2019
View article titled, In This Issue of <em>Diabetes Care</em>
Open the PDF for In This Issue of <em>Diabetes Care</em> in another window
Journal Articles

The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing

Matthew S. GoodSmith, M. Reza Skandari, Elbert S. Huang, Rochelle N. Naylor
Journal: Diabetes Care
Diabetes Care 2019;42(12):2247–2255
https://doi.org/10.2337/dc19-0486
Published: 26 September 2019
View article titled, The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing
Open the PDF for The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing in another window
Includes: Supplementary data
Journal Articles

Congenital Anomalies in Offspring of Maternal Glucokinase–Maturity-Onset Diabetes of the Young: A Case Report

Victoria L. Rudland, Jason Pinner, Glynis P. Ross
Journal: Diabetes Care
Diabetes Care 2019;42(10):e162–e163
https://doi.org/10.2337/dc19-0930
Published: 15 August 2019
View article titled, Congenital Anomalies in Offspring of Maternal Glucokinase–Maturity-Onset Diabetes of the Young: A Case Report
Open the PDF for Congenital Anomalies in Offspring of Maternal Glucokinase–Maturity-Onset Diabetes of the Young: A Case Report in another window
Journal Articles

Robert Tattersall, a Diabetes Physician Ahead of His Time

Simon R. Heller
Journal: Diabetes Care
Diabetes Care 2019;42(6):1005–1008
https://doi.org/10.2337/dci18-0063
Published: 10 May 2019
View article titled, Robert Tattersall, a Diabetes Physician Ahead of His Time
Open the PDF for Robert Tattersall, a Diabetes Physician Ahead of His Time in another window
Journal Articles

Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 2019;42:69–76

Jane Frances Grace Lustre Estrella, David Simmons
Journal: Diabetes Care
Diabetes Care 2019;42(5):e78
https://doi.org/10.2337/dc19-0043
Published: 15 April 2019
View article titled, Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 2019;42:69–76
Open the PDF for Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 2019;42:69–76 in another window
Journal Articles

Response to Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 2019;42:69–76

Stephanie R. Johnson, Hannah E. Carter, Paul Leo, Samantha A. Hollingworth, Elizabeth A. Davis, Timothy W. Jones, Louise S. Conwell, Mark Harris, Matthew A. Brown, Nicholas Graves, Emma L. Duncan
Journal: Diabetes Care
Diabetes Care 2019;42(5):e79–e80
https://doi.org/10.2337/dci19-0010
Published: 15 April 2019
View article titled, Response to Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 2019;42:69–76
Open the PDF for Response to Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life. Diabetes Care 2019;42:69–76 in another window
Journal Articles

In This Issue of Diabetes Care

Journal: Diabetes Care
Diabetes Care 2019;42(1):1–2
https://doi.org/10.2337/dc19-ti01
Published: 12 December 2018
View article titled, In This Issue of <em>Diabetes Care</em>
Open the PDF for In This Issue of <em>Diabetes Care</em> in another window